Medifast Reports Blowout Earnings!
October 30, 2009
Just a few short days ago, I posted an article singing the praises of Medifast Inc. (MED). If you remember, this is the doctor-approved, weight-loss option of choice for thousands of people.
Not only does the product seem to be a winner, the company and stock have been phenomenal as well. In fact, I ran the numbers, took a hard look at the company and tossed aside analysts' earnings estimates of 19 cents per share. This company has been growing at an incredible pace, and I targeted 21 cents per share.
Well, I was closer than the analysts, but even my estimate was conservative. MED reported earnings of 23 cents per share for a 21% surprise!
The company reported third-quarter net income of $3.4 million or 23 cents a share, 21% better than the consensus and a 109% increase over the same period last year! Medifast also reported a 65% increase in revenue to $45 million compared with a year ago thanks to high demand for its safe weight-loss options. Shares surged over 17% yesterday alone thanks to MED’s solid quarterly performance.
This was a great move for the company, and I hope you had a chance to get in on this stock, but if not, MED is still a great company with a bright future ahead and should continue to reward investors in the quarters to come.
Please remember that if you want to check on the health of any company, including MED, you can get the complete Stock Report FREE through Portfolio Grader.
- Story
Tools
bookmark
email
print
add to tip'd
save to del.icio.us
tweet this
Sign up for Louis' FREE Newsletter
| Louis Navellier on |
Follow Louis on |
||
| Subscribe to this RSS Feed |
Sign Up for Louis' Free Newsletter |
Today's Markets »
| DJIA | 10,318.16 | -14.28 | -0.14% | |
| NASDAQ | 2,146.04 | -10.78 | -0.50% | |
| S&P | 1,091.38 | -3.52 | -0.32% |
Most Popular »
- Buy Hewlett-Packard Before Earnings
- An 1849-Style Gold Rush in 2009
- Cashing In on the Wireless Revolution
- Cutting Edge Biotech Stocks to Buy Now
- 2 ETFs to Buy Now
Your Navellier Services
Subscribers log in below for complete portfolios, specific buy prices, up-to-the minute buy/sell/hold recommendations and more!
Not a subscriber? Sign up risk-free today.
To learn more about a Blue Chip Growth subscription, click here.
To learn more about an Emerging Growth subscription, click here.
To learn more about a Global Growth subscription, click here.
To learn more about a Quantum Growth subscription, click here.


